FOLD
Price
$10.34
Change
-$0.06 (-0.58%)
Updated
May 6, 6:59 PM EST
2 days until earnings call
TRDA
Price
$13.50
Change
+$0.34 (+2.58%)
Updated
May 6, 6:59 PM EST
3 days until earnings call
Ad is loading...

Analysis and predictions FOLD vs TRDA

Header iconFOLD vs TRDA Comparison
Open Charts FOLD vs TRDABanner chart's image
Amicus Therapeutics
Price$10.34
Change-$0.06 (-0.58%)
Volume$584.55K
CapitalizationN/A
Entrada Therapeutics
Price$13.50
Change+$0.34 (+2.58%)
Volume$12.64K
CapitalizationN/A
View a ticker or compare two or three
FOLD vs TRDA Comparison Chart

Loading...

FOLDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FOLD vs. TRDA commentary
May 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Buy and TRDA is a Buy.

COMPARISON
Comparison
May 07, 2024
Stock price -- (FOLD: $10.40 vs. TRDA: $13.16)
Brand notoriety: FOLD and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 48% vs. TRDA: 49%
Market capitalization -- FOLD: $3.06B vs. TRDA: $443.2M
FOLD [@Biotechnology] is valued at $3.06B. TRDA’s [@Biotechnology] market capitalization is $443.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $547.77B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, TRDA is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • FOLD’s TA Score: 5 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both FOLD and TRDA are a good buy in the short-term.

Price Growth

FOLD (@Biotechnology) experienced а +1.17% price change this week, while TRDA (@Biotechnology) price change was +5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.75%. For the same industry, the average monthly price growth was -3.30%, and the average quarterly price growth was +64.67%.

Reported Earning Dates

FOLD is expected to report earnings on Aug 01, 2024.

TRDA is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+3.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FOLD with price predictions.
OPEN
A.I.dvisor published
a Summary for TRDA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FOLD($3.06B) has a higher market cap than TRDA($443M). TRDA YTD gains are higher at: -12.790 vs. FOLD (-26.709).
FOLDTRDAFOLD / TRDA
Capitalization3.06B443M691%
EBITDAN/AN/A-
Gain YTD-26.709-12.790209%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDTRDA
RSI
ODDS (%)
Bullish Trend 4 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
74%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
FOLDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNGRX15.780.25
+1.61%
Franklin Intl Growth R
CICAX54.290.57
+1.06%
American Funds Invmt Co of Amer 529A
ERISX14.320.13
+0.92%
Parametric International Equity R
MISIX15.210.12
+0.80%
Victory Trivalent International Sm-Cp I
BVEFX19.540.10
+0.51%
Becker Value Equity Retail

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with MLYS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then MLYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.29%
MLYS - FOLD
53%
Loosely correlated
-1.07%
NTLA - FOLD
51%
Loosely correlated
+1.42%
BEAM - FOLD
50%
Loosely correlated
+1.80%
PCVX - FOLD
48%
Loosely correlated
+2.18%
DNLI - FOLD
47%
Loosely correlated
+1.96%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with TRVI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then TRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-2.95%
TRVI - TRDA
35%
Loosely correlated
+0.33%
ARDX - TRDA
34%
Loosely correlated
+28.42%
OVID - TRDA
33%
Loosely correlated
-0.33%
FOLD - TRDA
32%
Poorly correlated
-0.29%
SVRA - TRDA
32%
Poorly correlated
+0.53%
More